FindTrial
Sign In

Noninvasive Diagnostic Techniques in Determination of Site of Lesion of Auditory Neuropathy Spectrum Disorder

Noninvasive Diagnostic Techniques in Determination of Site of Lesion of Auditory Neuropathy Spectrum Disorder(ANSD)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05666466
Enrollment
25
Registered
2022-12-27
Start date
2022-12-01
Completion date
2024-12-30
Last updated
2022-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Auditory Neuropathy

Keywords

auditory neuropathy

Brief summary

cross-sectional study of population who have ANSD

Detailed description

Cross-sectional nonivasive study including study and control group aiming to determine site of lesion of auditory neuropathy spectrum disorder either presynaptic or postsynaptic by using electrophysiological measures

Interventions

DIAGNOSTIC_TESTextratympanic electrocochleograhy

electrophysiological test

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
12 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Age between 12 and 50 years OAE and CM could be present disproportionate SRS to PTA level

Exclusion criteria

proportionate ABR to PTA level Proportionate SRS to PTA level * presnce ol lesions in CT or MRI

Design outcomes

Primary

MeasureTime frameDescription
determination of site of lesion of ANSDone and half yeardifferentiation between presynaptic and postsynaptic types of ANSD

Countries

Egypt

Contacts

Primary ContactRania Khalil, MSc
rania.khalil@med.sohag.edu.eg00201024493093

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026